Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-034659
Filing Date
2004-03-04
Accepted
2004-03-04 16:33:35
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 940088
3 BYLAWS dex36.htm EX-3.6 99348
4 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 49929
5 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.htm EX-23.1 2177
6 302 CERTIFICATION OF CEO & CFO dex311.htm EX-31.1 18229
7 906 CERTIFICATION OF CEO & CFO dex321.htm EX-32.1 5260
  Complete submission text file 0001193125-04-034659.txt   1117163
Mailing Address 500 FORBES BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 500 FORBES BOULEVARD SOUTH SAN FRANCISCO CA 94080 6502663000
CELL GENESYS INC (Filer) CIK: 0000865231 (see all company filings)

EIN.: 943061375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19986 | Film No.: 04649196
SIC: 2834 Pharmaceutical Preparations